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Cryoglobulinemia is a pathological condition in which the
blood contains immunoglobulins that precipitate reversibly in
the cold. According to the most widely used classification,
based on the chemistry of the cryoglobulins involved, there are
three types of cryoglobulinemia [11. In type I cryoglobulinemia,
the cryoprecipitable immunoglobulin is a single monoclonal
immunoglobulin, usually a myeloma protein or a macroglobulin
[2, 3]. Type II and III cryoglobulinemia are both mixed cryo-
globulinemias, composed of at least two immunoglobulins. In
both, a polyclonal IgG is bound to another immunoglobulin,
which is an antiglobulin, that is, it acts as an anti-IgG rheuma-
toid factor [4]. The important difference between these two
types of mixed cryoglobulinemia is that in type lIthe antiglo-
bulin component, which is usually of the 1gM class, is mono-
clonal, while in type III it is polyclonal. As we will see later, this
difference probably reflects different pathogenetic mechanisms:
polyclonal anti-IgG immunoglobulins involved in type III cryo-
globulinemia are derived from perturbation and magnification of
the physiologic mechanism of production of antiglobulins con-
cerned with immunoregulation and are probably antigen-driven,
whereas the monoclonal anti-IgG immunoglobulins of type
Il-mixed cryoglobulinemia may be derived from the abnormal
proliferation of a special clone of B lymphocytes, probably as a
consequence of lymphoproliferative disorder [5].
In the last 20 years, cryoglobulinemia has been found in
association with an increasing variety of diseases [1, 6]. Type I
cryoglobulins are usually found in myelomas and Walden-
strom's macroglobulinemias. A great percentage of the mixed
cryoglobulinemias, which are 60 to 75% of all cryoglobuline-
mias [1, 7], are found in connective tissue diseases, in infectious
or lymphoproliferative disorders, in hepatobiliary diseases or in
immunologically-mediated glomerular diseases, and can there-
fore be considered "secondary mixed cryoglobulinemias".
However, for approximately 30% of all mixed cryoglobuline-
mias the etiology is not clear and the cryoglobulinemia is
referred to as "essential". The clinical syndrome of essential
mixed cryoglobulinemia (EMC) was first described by Meltzer
et al in 1966 [3]. It was characterized by purpura, weakness,
arthralgia, and in some of the patients by glomerular lesions.
Many subsequent reports have further defined this syndrome.
They also indicate that the incidence of EMC varies in different
geographical areas, the majority of cases having been reported
in the Mediterranean countries, namely Italy, France, Spain
and Israel [5, 6]. They have confirmed that the syndrome can be
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associated with either type II or type III cryoglobulins. In the
rheumatological surveys, patients with type III outnumbered
those with type II EMC [3, 7—10]. On the contrary, surveys
based on renal involvement indicated a large prevalence of type
II EMC, the monoclonal 1gM component being nearly always
an IgMk [10—12].
While the glomerular lesions were variable and non-specific
in the few cases of type III EMC with renal involvement, in
type II EMC, in which IgMk was the monoclonal component, a
particularly well characterized pattern of glomerular disease
has been described.
We will consider to this special subgroup of patients with
type II-EMC in this review, since we think that the description
of their renal disease may shed light on the more general
problem of the pathogenesis and mechanisms of glomerular and
vascular damage in immunologically-mediated renal diseases.
Renal pathology
Light microscopy findings
Glomeruli. In the majority of patients, a particular type of
membranoproliferative exudative glomerulonephritis (GN)
(Fig. 1), which has been called "cryoglobulinemic GN" by
Mazzucco et al [13], is found.
The pattern of the glomerular involvement differs from that of
the idiopathic type of membranoproliferative GN and from that
of the diffuse proliferative GN of systemic lupus in the following
characteristic features:
a) Endocapillary "proliferation" is due to an infiltration of
leucocytes, mainly monocytes, which is frequently massive.
This cell accumulation was described by Monga et al [13—15]
and has been confirmed by us [16, 171. We could count up to 80
cells per glomerulus after non-specific esterase staining (Fig. 2),
while no more than 20 cells are found in severe diffuse prolif-
erative lupus nephritis, and monocyte infiltration is usually
unimportant in idiopathic membranoproliferative GN [16].
More recently, using a panel of monoclonal antibodies to label
cell surface markers of different leucocytes, we confirmed that
up to four times as many total leucocytes can be counted in this
GN, in comparison with lupus-GN in which there are mainly
rnonocytes (Fig. 3). Some of them expressed the surface-related
anti-tissue factor procoagulant activity, when tested with the
specific monoclonal antibody. T lymphocytes with a prevalence
of OKT8+ cytotoxic suppressor lymphocytes were also present
[181.
b) In about 1/3 of all patients with this type of GN, and
especially in those with more acute renal disease and more
massive proliferation and exudation, amorphous, eosinophilic,
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Fig. 1. EMC-associated
membranoproliferative-exudative GN. The
picture shows marked intracapillary
hypercellularity, diffuse thickening of the
glomerular basement membrane with double-
contoured appearance and endoluminal
"thrombi" (Masson thrichrome, x 250).
Fig. 2. EMC-associated GN. Massive
intracapillary infiltration of monocytes (dark
cells) (esterase, x 250).
PAS-positive, Congo red-negative deposits of variable size and
distribution, lying against the inner side of the glomerular
capillary wall and sometimes filling the capillary lumen com-
pletely, the so-called "intraluminal thrombi" (Fig. 4), are
present [10—12, 17, 19].
c) Thickening of glomerular basement membrane, with a
double-contoured appearance, is more diffuse and evident than
in lupus nephritis and in idiopathic membranoproliferative GN
(Fig. 4). As seen with electronmicroscopy, the double contour
is mainly due to the peripheral interposition of monocytes,
while mesangial matrix and cell interposition is less evident
than in lupus nephritis and in idiopathic membranoproliferative
GN [13, 17].
In some patients the monocyte infiltration is less striking;
there are usually no intraluminal thrombi and the picture of
'cryoglobulinemic GN" we have described becomes less typ-
ical. Mild segmental mesangial proliferation, without significant
monocyte infiltration and capillary wall alterations, is found in
about 10% of our patients. Lobular GN, with prevalent mesan-
gial cell proliferation (but also monocyte infiltration), mesangial
matrix expansion and areas of centrolobular sclerosis, is some-
times found along with a clinical picture of intense proteinuria,
often in the nephrotic range (another 10% of our biopsied
patients). Only in this last small group of patients is mesangial
sclerosis a striking phenomenon. In the majority of patients
with EMC-GN, glomerular segmental and global sclerosis is
rather mild and inconstant even many years after the onset of
the renal disease, as we have shown by repeated biopsies. In
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Fig. 3. EMC-GN. Immunoperoxidase staining
of a cryostat section. There is prominent
intraglomerular mononuclear cell infiltration
which is positively labelled with the
monoclonal antibody to monocytes (0KM1).
Fig. 4. EMC-GN. At higher magnification
double contours and enormous endoluminal
"thrombi" are particularly evident (silver
stain, x 1000).
spite of the frequently advanced age of the patients, the mean
incidence in the total population of 100 patients studied in Milan
of obsolescent glomeruli was 6.2% [17].
In spite of the intense intracapillary proliferation and exuda-
tion, even in the more acute stages, extracapillary proliferation
is an uncommon finding. When present, it is always focal and
segmental, never circumferential.
Interstitium. Infiltration by mononuclear leucocytes is usu-
ally found in the acute stages of the renal disease. We demon-
strated that this infiltration is due to accumulation of mono-
cytes, dendritic cells and T lymphocytes, mainly OKT8÷
cytotoxic-suppressor lymphocytes [18]. In spite of this frequent
and marked infiltration, interstitial fibrosis is not a prominent
finding, even in late biopsies.
Vessels. In at least 1/3 of patients biopsied because of renal
disease and in a larger percentage of post-mortem specimens,
vasculitis of small and medium size arteries is found [7, 10, 17,
19]. It is seen more frequently in patients with acute clinical
pictures and intense membranoproliferative exudative GN,
with or without massive intraluminal thrombi, sometimes asso-
ciated with other signs of systemic vasculitis, but it can also be
found in the absence of obvious glomerular damage. It is
characterized by fibrinoid necrosis of the arteriolar wall, with
infiltration of monocytes around the wall, which in some cases
is granulomatous-like. In biopsies taken in later stages, perivas-
cular infiltration appears to be replaced by perivascular fibrosis.
Intimal fibrosis of interlobular arteries is often found in patients
with EMC, even in the absence of vasculitic lesions.
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Fig. 5. EMC-GN. Subendothelial deposit with
crystalloid structure, which in cross section
reveals to be made up of tubular units (arrow)
(original magnification, x 22000).
Electron microscopic findings
Electron dense deposits can be found in the capillary lumen,
usually in a subendothelial position, but sometimes also filling
the capillary lumen. They are sometimes amorphous immune
complex-like deposits, but often they have a peculiar fibrillar or
crystalloid structure [10, 12, 13, 19—23]. In IgG-IgMk EMC the
crystalloid structure, which is identical to that seen in the in
vitro cryoprecipitate of the same patients [21, 22], consists of
cylinders 100 or 1000 nm long which have a hollow axis. In
cross sections they look like annular bodies with a light center,
a dense ring and lighter peripheral protein coat (Fig. 5). The
crystalloid deposits, when present, are often surrounded by
areas of amorphous, weakly osmiophilic and translucent mate-
rial, attributed to deposit degradation. Both types of deposits
are infrequently seen in the mesangial area and subepithelial
ones are quite exceptional. Circulating aggregates or structured
material can sometimes be found in peritubular capillaries and
arterioles.
Ultrastructural examination confirms that monocytes in the
capillary lumina are mainly responsible for the intracapillary
proliferation in the acute stages, even though mesangial cell
proliferation and mesangial matrix increases can also be found.
Monocytes appear very often to be in close contact with the
subendothelial and intraluminal amorphous or crystalloid de-
posits and involved in their degradation. In fact, these cells
appear to be filled with large amorphous protein droplets with
different osmiophilia, which are probably products of phagocy-
toses (phagolysosomes) [14, 15, 23]. These intracellular protein
droplets do not have a crystalloid structure, suggesting that the
cryoglobulins lose their structure during phagocytosis. When a
large number of these monocytes with giant protein droplets
accumulate in the capillary lumen together with the amorphous
or crystalloid deposits, they contribute to the complete occlu-
sion of the lumen. Monocytes can frequently be found inter-
spersed with the subendothelial deposits, between the glomer-
ular basement membrane and the endothelial cells or the newly
formed basement membrane-like material, lying against its
inner side in those areas in which capillary walls are double-
contoured (Fig. 6). As we said, peripheral interposition of
mesangial matrix and cells is not as marked as in idiopathic
membranoproliferative GN, with the exception of the few cases
in which a typical picture of lobular GN is found by light
microscopy.
Immunohistological features
Three patterns of glomerular deposition can be seen by
immunofluorescence [10, 19, 24, 25]:
a) Intense massive staining of huge deposits that fill the
capillary lumen (intraluminal thrombi), usually associated with
faint irregular segmental parietal staining of some peripheral
loops, in a subendothelial position (Fig. 7);
b) The same pattern of faint irregular segmental parietal
staining of some peripheral loops, in a subendothelial position,
but without any intraluminal staining;
c) Intense granular diffuse staining of peripheral loops, with a
subendothelial pattern (Fig. 8).
1gM and IgG are the prevailing immunoreactants in type II
EMC, suggesting that the deposits are locally trapped or
precipitated cryoglobulins. This identity was confirmed by our
demonstration [26] that the immune deposits have antiglobulin
activity similar to that of the serum cryo-IgM. More recently,
using monoclonal antibodies against cross reactive idiotypes
present on rheumatoid factors, we have been able to identify
the same idiotype of the circulating monoclonal rheumatoid
factors, in renal biopsy specimens from patients with EMC-GN
[27] (Fig. 9).
C3 is present very frequently, with a distribution similar to
that of immunoglobulins, although with a lesser intensity, in the
parietal deposits, while intraluminal thrombi only occasionally
show positive fluorescence for complement components. De-
posits of earlier complement components (Ciq and C4) and
fibrinogen are also found in the parietal deposits in about 30% of
( 
•
i 
$ 
ik
7 
1008 D'Amico et a!: Essential mixed cryog!obu!inemia
Fig. 6. EMC-GN. The picture shows the
double contour appearance, with monocyte
interposition, in a capillary loop.
Subendothelial deposits are also present
(original magnification, x 3600).
Fig. 7. EMC-GN. Intense massive staining of
intraluminal "thrombi", filling capillary
lumina, associated with irregular segmental
staining along the capillary walls (IgG, x 400).
cases [10, 12, 24]. Vascular deposits of 1gM, IgO, C3 and disease (purpura, arthralgias, systemic vasculitis) is not infre-
fibrinogen are detected in about 1/3 ofcases. quent. In some of our patients, the renal involvement was the
presenting manifestation of the disease and made diagnosis
Clinical features possible even before the appearance of purpura [10].
Age and sex
Type II EMC manifests itself usually from the fourth to fifth Renal symptoms at presentation
decade of life, although the first presentation has been reported The most frequent presenting clinical syndrome is an isolated
for younger patients, Women outnumber men in non-selected proteinuria with microscopic hematuria, sometimes associated
populations [10]. This difference is smaller in patients with ON, with signs of moderate chronic renal insufficiency. An acute
but in our selected population women were still more numerous nephritic syndrome, characterized by hematuria, usually mac-
than men [28]. roscopic, by severe proteinuria, hypertension and a sudden rise
Renal involvement is usually a late complication of EMC, but in BUN, is present at the onset of the renal disease in nearly
the concomitant appearance of renal and systemic signs of the 25% of cases and is complicated by acute oliguric renal failure
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Fig. 8. EMC-GN. Granular deposits of 1gM
along the capillary walls in a diffuse,
subendothelial pattern (x 400).
Fig. 9. EMC-assocjated GN. Staining with MoAbCc I shows granular staining of the capillary walls with characteristic lobular outline pattern
(indirect immunofluorescence, )< 300).
in no more than 5% of them. Finally, a nephrotic syndrome,
often not severe clinically, is found at presentation in another
20% of patients [5, 25]. Arterial hypertension is very frequently
found at the time of the apparent onset of renal disease, even in
patients without nephritic syndrome. It was found at presenta-
tion in 84 of the 100 patients studied in Milan [25].
Natural history and prognosis
The renal disease has a variable course. For nearly 1/3 of
patients, partial or complete remission of renal symptoms has
been described, even though at presentation there was an acute
nephritic syndrome or a severe nephrotic syndrome. In another
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30% of cases, the renal disease has a rather indolent course and
does not progress to renal failure for several years, in spite of
the persistence of urinary abnormalities. In as many as 20% of
patients, reversible clinical exacerbations, such as nephritic
syndrome, occur during the course of the disease, sometimes
associated with flare-ups of the systemic signs of the disease.
More than one episode of exacerbation may occur in a single
patient, at variable intervals.
A moderate degree of renal insufficiency, if not already
present at the clinical onset, is frequently found in later stages.
However, progression to end-stage renal failure is less common
than was believed in the past, even in patients with multiple
relapses of the renal disease. Chronic uremia developed, usu-
ally several years after the onset of renal symptoms, in only
10% of the patients reported in the literature [12]. After a mean
follow-up of more than 10 years, only 6 of 108 patients with
renal involvement studied in Milan required regular dialysis
treatment, while 27 had died because of extrarenal complica-
tions [28]. The most frequent causes of death in EMC are
systemic vasculitis, infections, cardiovascular and cerebrovas-
cular accidents. The two last of these are certainly favored by
the arterial hypertension, which is not only an early and very
common complicating sign, but is also frequently severe and
difficult to control, and may have an accelerated course in some
patients [7, 10, 12, 28—31].
It has been stated in the past that the outcome for patients
with EMC is worse if renal involvement occurs [7, 9, 28, 32].
This is no longer correct, probably because of a better thera-
peutic approach to the disease and its complications. In our
series of more than 100 patients with EMC and renal involve-
ment, the mortality rate was 30% at 10 years after the beginning
of the disease, similar to that previously reported for patients
without renal disease [321.
All the extrarenal symptoms of EMC, that is, purpura,
arthralgia, peripheral neuropathy, hepatic involvement, may
appear in the patients with renal involvement with the same
frequency as in those who do not show signs of renal disease
[101. The existence of multiple extrarenal symptoms, and in
particular of those that suggest systemic vasculitis, is associ-
ated with more severe renal involvement [25] and with a worse
prognosis [28].
Laboratory findings
The amounts of circulating cryoglobulins may vary from one
patient to the other, and in the same patient at different times.
We found cryocrits ranging between 2 and 70%, with large
variations during the course of the disease. Serum titers of 1gM
rheumatoid factor are also frequently elevated. There is no
correlation between these laboratory parameters and the degree
of activity of the disease [10, 30, 31], but high cryoglobulin
concentrations have correlated with a bad prognosis in our
experience [281.
The serum complement pattern is rather specific in EMC
nephritis. Early complement components (Cjq, C4) and CH5O
are usually very low. C3 is slightly but significantly low and later
components (C5 and C9), C3PA and C1INH tend to be higher
than in normal controls [10, 12, 33, 34]. The C3 breakdown
product C3d is sometimes increased.
The complement pattern does not change very much with
changes in clinical activity of the disease. In fact, early corn-
plement components tend to remain low, whatever the degree
of activity of the systemic or renal disease [10, 12, 33].
Positivity for markers of type B viral hepatitis infection, and
in particular of persistent HBs antigenemia, have been reported
with variable frequency by different investigators. In some
reports the laboratory signs indicating such viral infection were
so frequent that they were considered a possible cause of the
systemic disease [35—37]. In other reports, even in the same
geographical areas, the incidence of HBs antigenemia and viral
hepatitis were not abnormal in the patients [28, 32].
Clinico-pathological correlations
The histological picture of severe membranoproliferative
exudative GN, characterized by massive monocyte infiltration,
especially when intraluminal deposits are also present, is al-
ways associated with an acute nephritic syndrome and marked
proteinuria. Such a picture in patients with a clinical syndrome
of abrupt onset usually shows the immunohistological pattern of
deposition shown in Figure 7, that is, massive intraluminal
staining with only faint segmental parietal deposition of immu-
noglobulins and complement [25]. This clinical syndrome is
promptly reversible, especially if treatment is instituted early,
and repeat biopsies in subsequent phases of remission of the
clinical signs of renal disease, after a few months or even
weeks, demonstrate reduction of monocyte infiltration and
complete disappearance of intraluminal thrombi. The pattern of
deposition at immunofluorescence at this stage shows faint
segmental parietal staining of some peripheral loops, in a
subendothelial position, or there may be no deposits at all. On
the contrary, in cases in whom the first biopsy, performed
during phases of clinical remission shows minimal histological
lesions or mild proliferative-exudative GN without thrombi, a
repeat biopsy performed during acute exacerbation shows
aggravation of the monocyte infiltration and sometimes the
appearance of huge intraluminal deposits with the pattern
shown in Figure 7. Signs of renal vasculitis may also be found
during the presenting acute renal syndrome or the recurring
stages of clinical relapse, especially if signs of systemic vascu-
litis are present. In a few patients, such signs of renal vasculitis
are not associated with severe glomerular lesions, indicating
that the immunological phenomena that trigger vascular and
glomerular damage may not be associated.
The more vague indolent clinical syndrome of severe protein-
uria, sometimes in the nephrotic range, which is also frequent in
patients with EMC, is usually associated with a picture of much
proliferation and infiltration of monocytes, with evident thick-
ening of the glomerular basement membrane or with a picture of
lobular membranoproliferative UN, and with an immunohisto-
logical picture of intense diffuse subendothelial deposition (Fig.
8). Except for the centrolobular sclerosis, even these histolog-
ical and immunohistological pictures are partially reversible,
changing to the picture of mild mesangial proliferation, with
faint segmental deposition at immunofluorescence, which is
usually associated with the less severe renal syndrome charac-
terized by isolated urinary abnormalities.
Plasma creatinine levels are often temporarily increased
when an acute nephritic syndrome is associated with the
presence of massive intraluminal thrombi. Moderate renal
insufficiency can also be observed in a more stable way in
membranoproliferative GN without thrombi, characterized by
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subendothelial intense deposition of IgG and C3, but on the
average the degree of renal insufficiency and the cryocrit levels
and complement profile did not significantly differ in our pa-
tients with different histological patterns [25]. On the contrary,
there was a significant correlation between extension and
severity of systemic involvement and severity of the glomerutar
involvement [251.
Pathogenesis of type II EMC
There is sufficient evidence, in our opinion, to believe that the
primary abnormality of type II EMC is the production of a
monoclonal 1gM rheumatoid factor, and therefore that this
disease falls within the spectrum of lymphoproliferative disor-
ders. However, patients show very little evidence of lymphoid
malignancy (with rare exceptions of late progression to lym-
phoma). The dominant manifestations of the disease result from
the tissue deposition of IgM/IgG immune complexes.
The location arid magnitude of the clone responsible for the
rheumatoid factor production is now being investigated, using a
panel of mouse monoclonal rheumatoid factors. An increased
percentage of idiotype-positive (t+) B cells has been found in
both peripheral blood and in morphologically normal bone
marrow of all patients tested [38]. Preliminary data demonstrat-
ing immunoglobulin-gene rearrangements in the DNA extracted
from peripheral blood B cells (and lymph node cells) further
strengthen this concept [39]. We have also found that peripheral
B lymphocytes from EMC patients produce larger quantities of
1gM-rheumatoid factor than normal mononuclear cells, both
spontaneously and after in vitro stimulation with pokeweed
mitogen [40].
It is possible that the polyclonal IgG, to which monoclonal
1gM binds, is already bound to an antigen to form immune
complexes, so that monoclonal 1gM acts as an anti-immune
complex antibody. However, such antigens have not yet been
identified in the majority of cases. HBs has been considered a
possible antigen for a minority of patients [36, 37]. Antigens
related to coccidodiomycosis were suspected to be the initiating
antigen for one case [41]. We have recently demonstrated the
presence of 1gM anti-viral capsid antigen of Epstein-Barr virus
in a great number of patients with type II EMC [42]. More
recently, we have detected by DNA studies that the Epstein-
Barr virus genome was incorporated into the bone marrow cells
of all tested individuals with type II, but not with type III,
cryoglobulinemia, suggesting an association between type II-
EMC and persistent Epstein-Barr virus infection [43]. This is
quite interesting, especially since in vitro infection of peripheral
blood lymphocytes with EBV is known to induce the synthesis
of 1gM anti-IgG antibody and the development of permanent
cell lines [441.
It is still debated whether monoclonal 1gM rheumatoid factor
of type II cryoglobulins is always bound to the Fc portion of
polyclonal IgG or might react in some cases against the IgG's
F(ab')2 fragments, acting as an anti-idiotypic antibody [45]. The
inverse possibility that IgG might react as an antiidiotype
against the hypervariable portion of 1gM light chains has also
been raised [461.
Whatever the mechanism of binding, the mechanism of
cryoprecipitation of the immunoglobulins involved in type II
cryoglobulinemia is still unclear. Intrinsic physicochemical
properties of the single components are not sufficient to explain
the phenomenon, since it has been demonstrated that both
immunoglobulins must be present for cryoprecipitation to take
place [47—49]. Factors such as antigen-antibody ratio [50],
Fc-Fc interactions [51], reduced solubility due to hypocomple-
mentemia [52], binding with fibronectin [53] and hydrophobic
properties of proteins [54] have all been considered.
Treatment
The possibility of spontaneous recovery from the acute
exacerbations of the renal disease in EMC must be taken into
consideration in evaluating the effectiveness of any proposed
treatment. A comparative analysis of the results for patients
with renal exacerbations treated with oral steroids and/or
cyclophosphamide and for untreated patients did not show any
significant advantage of the traditional immunosuppressive
therapy [55].
More convincing data about the effectiveness of two forms of
treatment have recently been obtained. The first consists of
short courses of methylprednisolone pulses [55], which were
proposed to obtain the most cytotoxic and anti-inflammatory
effects with the least side effects. The second consists of the
various techniques of plasma exchange [10, 45, 56, 57] to
remove significant amounts of circulating cryoglobulins, pre-
vent their intravascular precipitation and restore the functional
capacity of the overloaded reticuloendothelial system.
However, to avoid increased rebound after removal, plasma-
pheresis is usually associated with immunosuppressive therapy,
and it is therefore difficult to assess to what extent the beneficial
effects are attributable to plasma exchange per Se.
We have used plasma exchange to treat 15 patients with
clinical flare ups characterized by acute exacerbation of extra-
renal signs and rapid deterioration of renal function [10]. This
was associated with acute nephritic syndrome or acute renal
failure in 10 cases, and with impressive increase in proteinuria
in the other 5 (signs of systemic vasculitis were also present in
10 cases). All the patients were given cyclophosphamide and 14
of the 15 steroids as well (i.v, pulses of methylprednisolone for
3 of them), together with a variable number of plasma ex-
changes (13 on the average). We obtained rapid significant
decreases in cryocrit, serum creatinine and proteinuria in all
cases, while mean C3 and C4 levels did not change significantly.
In spite of the difficulties in evaluating the role of the individual
therapeutic procedures, until controlled trials become available
(and they are certainly needed), we think that simultaneous use
of steroids (starting with i.v. pulses), cytotoxic drugs such as
cyclophosphamide, and plasma exchange is warranted to con-
trol the more severe renal exacerbations, especially if signs of
systemic vasculitis are present.
It is still debated whether certain treatments are also justified
in the less acute stages of the renal disease, to avoid recur-
rences of the renal and systemic signs. Protracted immunosup-
pression with maintenance doses of cyclophosphamide is used
by us with caution, since patients with EMC are prone to
infection, while intermittent plasma exchange as long-term
treatment for preventing acute exacerbations, which has been
recently proposed [58], does not seem to be supported by a
scientific basis. Alpha-interferon, an inhibitor of B cell prolif-
eration, has been recently proposed for treatment of cryoglob-
ulinemic patients [59], but it needs further investigation.
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Pathophysiology of the renal damage in type II EMC
Concluding remarks
EMC-GN is an immune complex glomerulonephritis. The
cryoprecipitating immunoglobulins in the capillary lumina seen
by electron microscopy, the immunohistological demonstration
of subendothelial deposits of the same immunoglobulin classes
present in the circulating cryoglobulins and of complement,
suggest that cryoglobulins act in the glomerulus as trapped
immune complexes that bind complement. However, it can be
also postulated that local precipitation takes place because of
less specific physico-chemical mechanisms, as a consequence
of higher intracapillary cryoglobulin concentration induced by
the filtration process in the glomerulus [601. This second mech-
anism seems to be at work in cases in whom massive intralu-
minal accumulation of cryoglobulins is found histologically,
together with an immunofluorescence pattern of almost exclu-
sively intraluminal staining of thrombi. Two main clinico-
histological syndromes that correspond to these two mecha-
nisms of glomerular deposition of cryoglobulins are:
a) Time-limited, sometimes recurrent, bouts of intense cryo-
globulin precipitation in the glomerulus, which give rise to
reversible acute nephritic syndromes and to the histological
picture of membranoproliferative exudative GN with thrombi,
which is also reversible when the accumulated monocytes and
precipitated intraluminal cryoglobulins have been disposed.
b) A more discrete clinical syndrome, characterized by
urinary abnormalities, sometimes with proteinuria in the ne-
phrotic range, associated with the prevalent deposition of
cryoglobulins (and possibly of other circulating immune com-
plexes) on the subendothelial aspect of the glomerular basement
membrane and with a histological picture of membranoprolifer-
ative exudative GN, sometimes of the lobular type, without
thrombi and with variable degrees of monocytic exudation.
This latter syndrome is accompanied, for unknown reasons,
by activation and expansion of mesangial cells and matrix,
which are less marked and more slowly progressing than in
idiopathic membranoproliferative GN. Therefore, mesangial
sclerosis and progressive irreversible impairment of renal func-
tion are indolent, inconstant phenomena even in untreated
EMC-GN.
Whatever the prevailing mechanism for their deposition in
the glomerulus may be, locally trapped cryoglobulins trigger
intracapillary accumulation of monocytes from the blood
stream. We have demonstrated that, as in systemic lupus with
renal damage, these monocytes have an increased procoagulant
activity, both in the circulation [6] and in the renal tissue [181,
and are probably activated monocytes.
The presence of a large number of monocytes in the capillary
lumina and in the double contoured capillary walls of the
glomeruli is the hallmark of the disease. These cells accumulate
not only during the first, more acute clinical-histological syn-
drome (in these circumstances up to 80 cells per glomerulus
may be counted), but also in the more chronic phases of the
renal disease. Monocytes in the renal tissue act as scavenger
cells, as is suggested by the presence of large phagolysosomes
in their cytoplasm and by their close contact with the deposits
of cryoglobulins. But it is highly probable that they also behave
as mediators of the local damage, through liberation of lytic
enzymes and other humoral factors able to induce proliferation
of resident cells [62].
Since T lymphocytes, mainly T cytotoxic-suppressor lym-
phocytes, accumulate with monocytes both in the glomerulus
and in the interstitium, the participation of cellular immunity in
this type of renal damage must be considered.
A few comments need to be made about the role of glomer-
ular and interstitial accumulation of monocytes in type II EMC
as mediators of the renal damage in immunologically-driven
renal diseases.
a) Monocytes, even if present for long periods of time in the
renal tissue of humans, do not necessarily induce a rapidly
progressive course of the renal disease with severe proliferation
of intrinsic cells and subsequent sclerotic damage; in fact, as we
have said, end-stage renal failure and glomerular sclerosis are
uncommon phenomena in the EMC-GN, even after a duration
of many years of chronic renal disease and after one or more
episodes of massive reversible accumulation of monocytes and
T lymphocytes. This suggests that there may be different types
or degrees of local "activation" of monocytes, some of which
trigger a more marked damage than others.
b) In spite of similar histological pictures of membranopro-
liferative GN with subendothelial deposits, accumulation of
monocytes may be quite different with different types of depos-
its. Type II cryoglobulins trigger massive accumulation. Sub-
endothelial immune complexes typical of proliferative lupus
nephritis cause a less conspicuous but still visible infiltration.
Immune complexes deposited in the subendothelial position in
idiopathic membranoproliferative GN do not attract monocytes
at all. Even among structured deposits, deposits of immunotac-
toid GN do not attract monocytes (unpublished observation).
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